Freudenberg Medical, a developer and manufacturer of finished medical devices and subassemblies, components, and minimally invasive solutions, has announced several new solutions:
- The new Composer XL Deflectable Catheter Handle Platform, a commercialization-ready interface sized for large-bore structural heart and endovascular devices such as transcatheter tricuspid and mitral valve delivery systems.
- The HyperSeal XL, a design option for vascular access applications up to 30Fr and 40Fr.
- The 8.5F and 12Fr Composer Steerable Introducers, finished device solutions for private label development and customization across a wide range of electrophysiology, structural heart, and vascular applications.
“Building on the strong market response of our Composer Deflectable Catheter Handle Platform and Hemostasis Valve Family, Freudenberg Medical’s new Composer XL and HyperSeal XL were developed to address the unique challenges with large bore vascular access and device delivery in the rapidly evolving transcatheter valve and endovascular space. The significantly larger size of these emerging therapeutic devices are demanding innovative and unconventional solutions to reduce risk and improve outcomes,” said Bernie Kaeferlein, director of portfolio management at Freudenberg Medical, in a news release. “As a partner for innovation, we are committed to proactively addressing unmet clinical needs and offering our medical device customers a growing portfolio of finished device, design, and process solutions to help improve efficiency and accelerate their time to market.“
[Image courtesy of FREUDENBERG MEDICAL]